Header Logo

Connection

Ingrid Binswanger to Naltrexone

This is a "connection" page, showing publications Ingrid Binswanger has written about Naltrexone.
Connection Strength

0.687
  1. Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone. Drug Saf. 2018 10; 41(10):979-980.
    View in: PubMed
    Score: 0.643
  2. Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems. J Subst Abuse Treat. 2020 03; 112S:41-48.
    View in: PubMed
    Score: 0.044

© 2024 Kaiser Permanente